0 Mėgstami
0Krepšelis

FORMULATION EVALUATION OF BILAYER TABLET OF SAXAGLIPTIN & REPAGLINIDE

87,65 
87,65 
2025-07-31 87.6500 InStock
Nemokamas pristatymas į paštomatus per 16-20 darbo dienų užsakymams nuo 19,00 

Knygos aprašymas

In the present research work, an attempt has been made to optimize and formulate bilayer tablet of saxagliptin and repaglinide to achieve immediate release of saxagliptin and sustained release of repaglinide.Saxagliptin is DPP-4 inhibitor and belonging to BCS class 1 (high solubility, high permeability). It has long half life, so an attempt was made to achieve its fast action by making immediate release tablet by using superdisintegrant sodium starch glycolate..Repaglinide is an oral blood glucose-lowering drug of the maglitinide class used in the management of type 2 diabetes mellitus. It is absorbed by oral route and has short half life, so an attempt has been done to make sustained release tablet of repaglinide And it was concluded that the optimized formula RG4 (75 mg) drug (98.6 %) in 12 hrs. So by taking both optimized formulation in fixed dose combination in different layer. A bilayer tablet was prepared with 50 mg saxagliptin and 500 mg of repaglinide.

Informacija

Autorius: Anjali Soni, Dharmendra Solanki, Priyanka Yadav,
Leidėjas: LAP LAMBERT Academic Publishing
Išleidimo metai: 2023
Knygos puslapių skaičius: 104
ISBN-10: 6206142892
ISBN-13: 9786206142898
Formatas: Knyga minkštu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „FORMULATION EVALUATION OF BILAYER TABLET OF SAXAGLIPTIN & REPAGLINIDE“

Būtina įvertinti prekę

Goodreads reviews for „FORMULATION EVALUATION OF BILAYER TABLET OF SAXAGLIPTIN & REPAGLINIDE“